{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:52:38Z","timestamp":1773294758943,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/jcp.0b013e318150c80e","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T07:02:59Z","timestamp":1189580579000},"page":"517-519","source":"Crossref","is-referenced-by-count":9,"title":["Acute Urinary Retention Associated With Selective Serotonin Reuptake Inhibitors and Ziprasidone"],"prefix":"10.1097","volume":"27","author":[{"given":"Albert K.K.","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew-eng","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"3","key":"R1-21-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004714-199106000-00004","article-title":"High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.","volume":"11","author":"Beasley","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"R4-21-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1520-6777(2001)20:1<105::AID-NAU12>3.0.CO;2-9","article-title":"Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats.","volume":"20","author":"Seki","year":"2001","journal-title":"Neurourol Urodyn"},{"issue":"suppl 4a","key":"R5-21-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0090-4295(03)00754-4","article-title":"Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.","volume":"62","author":"Thor","year":"2003","journal-title":"Urology"},{"issue":"1","key":"R6-21-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.ju.0000118381.04432.22","article-title":"Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.","volume":"172","author":"Thor","year":"2004","journal-title":"J Urol"},{"issue":"suppl 4A","key":"R8-21-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0090-4295(03)00590-9","article-title":"Serotonergic modulation of bladder afferent pathways.","volume":"62","author":"Burgard","year":"2003","journal-title":"Urology"},{"key":"R9-21-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"key":"R10-21-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/00207450490430552","article-title":"Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?","volume":"114","author":"Tyson","year":"2004","journal-title":"Int J Neurosci"},{"issue":"suppl 19","key":"R11-21-20210128","first-page":"6","article-title":"The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.","volume":"64","author":"Stahl","year":"2003","journal-title":"JClin Psychiatry"},{"issue":"3","key":"R12-21-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","article-title":"Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a 35S GTPgammaS binding study.","volume":"355","author":"Newman-Tancredi","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"R13-21-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.","volume":"50","author":"Owens","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"6","key":"R14-21-20210128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neruopsychopharmacol"},{"key":"R15-21-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel anti-psychotic agent with a unique human receptor binding profile.","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"R16-21-20210128","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2210-1-4","article-title":"Effects of 2 atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats.","volume":"1","author":"Vera","year":"2001","journal-title":"BMC Pharmacol"},{"key":"R17-21-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/070674379604100922","article-title":"Urinary retention with fluoxetine-haloperidol combination in a young patient.","volume":"41","author":"Benazzi","year":"1996","journal-title":"Can J Psychiatry"},{"key":"R18-21-20210128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/026988110101500201","article-title":"Urinary retention caused after fluoxetine-risperidone combination.","volume":"15","author":"Bozikas","year":"2001","journal-title":"J Psychopharmacol"},{"key":"R19-21-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0924-9338(01)00612-5","article-title":"Association between severity of schizophrenic symptoms and urinary retention.","volume":"16","author":"Shiloh","year":"2001","journal-title":"Eur Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200710000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:12:45Z","timestamp":1618035165000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200710000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318150c80e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}